Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges.

MLA

Gianazza, Erica, et al. “Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges.” International Journal of Molecular Sciences, vol. 24, no. 4, Feb. 2023, p. 3291. EBSCOhost, https://doi.org/10.3390/ijms24043291.

APA

Gianazza, E., Brioschi, M., Iezzi, A., Paglia, G., & Banfi, C. (2023). Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. International Journal of Molecular Sciences, 24(4), 3291. https://doi.org/10.3390/ijms24043291

Chicago

Gianazza, Erica, Maura Brioschi, Ada Iezzi, Giuseppe Paglia, and Cristina Banfi. 2023. “Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges.” International Journal of Molecular Sciences 24 (4): 3291. doi:10.3390/ijms24043291.